MedPath

A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
Registration Number
NCT00000908
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to see how often Pneumocystis carinii pneumonia (PCP) occurs in HIV-positive patients who have stopped taking medications that help prevent PCP.

The risk of developing PCP may be decreased when an HIV-positive patient's CD4 cell counts (cells of the immune system which fight infection) are more than 200 cells/mm3. This study looks at whether it is acceptable to stop PCP prevention treatment in these patients.

Detailed Description

The risk of developing PCP may be decreased with treatment-induced recovery of CD4 counts to \> 200 cells/mm3. Few data exist to confirm or negate the continued necessity of PCP prophylaxis for such patients. This study will assess the effects of discontinuing therapy.

Subjects are asked to discontinue PCP prophylaxis if antiretroviral therapy has resulted in a sustained CD4 increase greater than 200 cells/mm3 on two measurements at least 12 weeks apart. They will be evaluated for symptoms and CD4 counts every 8 weeks as well as plasma for HIV-RNA every 16 weeks for 18 months. Subjects whose CD4 count falls to less than 150 cells/mm3 or between 150 and 200 cells/mm3 will have the CD4 count re-evaluated immediately or within 4 weeks. If the second CD4 count is less than 200 cells/mm3 for either case, conventional PCP prophylaxis will be resumed and the subject will be followed on study. Subjects will be followed during study by physical exams and laboratory tests at Weeks 4, 8, and every 8 weeks thereafter.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (54)

Kaiser Permanente LAMC

🇺🇸

Los Angeles, California, United States

Marin County Specialty Clinic

🇺🇸

San Rafael, California, United States

Rush Presbyterian - Saint Luke's Med Ctr

🇺🇸

Chicago, Illinois, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

St Louis Regional Hosp / St Louis Regional Med Ctr

🇺🇸

St. Louis, Missouri, United States

Ohio State Univ Hosp Clinic

🇺🇸

Columbus, Ohio, United States

Philadelphia Veterans Administration Med Ctr

🇺🇸

Philadelphia, Pennsylvania, United States

Univ of Pennsylvania at Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Univ of Pittsburgh Med Ctr

🇺🇸

Pittsburgh, Pennsylvania, United States

Univ of Colorado Health Sciences Ctr

🇺🇸

Denver, Colorado, United States

Queens Med Ctr

🇺🇸

Honolulu, Hawaii, United States

Univ of Hawaii / Leahi Hosp

🇺🇸

Honolulu, Hawaii, United States

Univ of Southern California / LA County USC Med Ctr

🇺🇸

Los Angeles, California, United States

San Francisco AIDS Clinic / San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Willow Clinic

🇺🇸

Menlo Park, California, United States

Univ of California / San Diego Treatment Ctr

🇺🇸

San Diego, California, United States

Louis A Weiss Memorial Hosp

🇺🇸

Chicago, Illinois, United States

Beth Israel Med Ctr

🇺🇸

New York, New York, United States

Bellevue Hosp / New York Univ Med Ctr

🇺🇸

New York, New York, United States

Division of Inf Diseases/ Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Univ of Rochester Medical Center

🇺🇸

Rochester, New York, United States

Univ of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

Case Western Reserve Univ

🇺🇸

Cleveland, Ohio, United States

Univ of Washington

🇺🇸

Seattle, Washington, United States

Univ of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Beth Israel Deaconess Med Ctr

🇺🇸

Boston, Massachusetts, United States

Univ of Puerto Rico

🇵🇷

San Juan, Puerto Rico

Howard Univ

🇺🇸

Washington, District of Columbia, United States

Julio Arroyo

🇺🇸

West Columbia, South Carolina, United States

Beth Israel Deaconess - West Campus

🇺🇸

Boston, Massachusetts, United States

Univ of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Kaiser Foundation Hosp

🇺🇸

Harbor City, California, United States

Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium

🇺🇸

San Jose, California, United States

San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Northwestern Univ Med School

🇺🇸

Chicago, Illinois, United States

SUNY / Erie County Med Ctr at Buffalo

🇺🇸

Buffalo, New York, United States

Methodist Hosp of Indiana / Life Care Clinic

🇺🇸

Indianapolis, Indiana, United States

St Mary's Hosp (Univ of Rochester/Infectious Diseases)

🇺🇸

Rochester, New York, United States

Duke Univ Med Ctr

🇺🇸

Durham, North Carolina, United States

Univ of Kentucky Lexington

🇺🇸

Cincinnati, Ohio, United States

Cook County Hosp

🇺🇸

Chicago, Illinois, United States

Chelsea Ctr

🇺🇸

New York, New York, United States

San Mateo AIDS Program / Stanford Univ

🇺🇸

Stanford, California, United States

Univ of Nebraska Med Ctr

🇺🇸

Omaha, Nebraska, United States

Univ of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Stanford Univ Med Ctr

🇺🇸

Stanford, California, United States

Emory Univ

🇺🇸

Atlanta, Georgia, United States

Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Harvard (Massachusetts Gen Hosp)

🇺🇸

Boston, Massachusetts, United States

Boston Med Ctr

🇺🇸

Boston, Massachusetts, United States

Mount Sinai Med Ctr

🇺🇸

New York, New York, United States

Cornell Univ Med Ctr

🇺🇸

New York, New York, United States

Univ of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

MetroHealth Med Ctr

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath